An open label study of Zonegran (zonisamide) in patients with partial onset seizures

To determine the efficacy and safety of adjunctive open label zonisamide treatment in patients with refractory partial seizures

Indicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation